Biblio

Export 4809 results:
Author Title Type Year
Filters: First Letter Of Last Name is A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Aged
R. Lizio, Del Percio, C., Marzano, N., Soricelli, A., Yener, G. G., Başar, E., Mundi, C., De Rosa, S., Triggiani, A. Ivano, Ferri, R., Arnaldi, D., Nobili, F. Mariano, Cordone, S., Lopez, S., Carducci, F., Santi, G., Gesualdo, L., Rossini, P. M., Cavedo, E., Mauri, M., Frisoni, G. B., and Babiloni, C., “Neurophysiological assessment of Alzheimer's disease individuals by a single electroencephalographic marker.”, J Alzheimers Dis, vol. 49, no. 1, pp. 159-77, 2016.
J. - P. Coutu, Goldblatt, A., H Rosas, D., and Salat, D. H., “White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 329-42, 2016.
G. J. Kinsella, Ames, D., Storey, E., Ong, B., Pike, K. E., Saling, M. M., Clare, L., Mullaly, E., and Rand, E., “Strategies for improving memory: a randomized trial of memory groups for older people, including those with mild cognitive impairment.”, J Alzheimers Dis, vol. 49, no. 1, pp. 31-43, 2016.
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., “Validation of the Spanish version of the Baylor Profound Mental Status Examination.”, J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
H. Li, Zhu, H., Wallack, M., Mwamburi, M., Abdul-Hay, S. O., Leissring, M. A., and Qiu, W. Qiao, “Age and its association with low insulin and high amyloid-β peptides in blood.”, J Alzheimers Dis, vol. 49, no. 1, pp. 129-37, 2016.
S. Agostini, Mancuso, R., Baglio, F., Cabinio, M., Hernis, A., Guerini, F. Rosa, Calabrese, E., Nemni, R., and Clerici, M., “Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 229-35, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
G. Berge, Lauridsen, C., Sando, S. Botne, Holder, D. Joseph, Møller, I., Aasly, J. Olav, Bråthen, G., Savage, M. Josephine, and White, L. Rosemary, “Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.”, J Alzheimers Dis, vol. 49, no. 2, pp. 493-502, 2016.
D. Jigar Shah, Rohlfing, F., Anand, S., W Johnson, E., Alvarez, M. H. Tanielle B., Cobell, J., King, J., Young, S. A., Kauwe, J. S. K., and Graves, S. W., “Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 317-27, 2016.
D. Jigar Shah, Rohlfing, F., Anand, S., W Johnson, E., Alvarez, M. H. Tanielle B., Cobell, J., King, J., Young, S. A., Kauwe, J. S. K., and Graves, S. W., “Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 317-27, 2016.
A. Madhavan, Schwarz, C. G., Duffy, J. R., Strand, E. A., Machulda, M. M., Drubach, D. A., Kantarci, K., Przybelski, S. A., Reid, R. I., Senjem, M. L., Gunter, J. L., Apostolova, L. G., Lowe, V. J., Petersen, R. C., Jack, C. R., Josephs, K. A., and Whitwell, J. L., “Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 633-43, 2016.
J. Ahdidan, Raji, C. A., DeYoe, E. A., Mathis, J., Noe, K. Ø., Rimestad, J., Kjeldsen, T. K., Mosegaard, J., Becker, J. T., and Lopez, O., “Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging.”, J Alzheimers Dis, vol. 49, no. 3, pp. 723-32, 2016.
O. Elkana, Eisikovits, O. Reichman, Oren, N., Betzale, V., Giladi, N., and Ash, E. L., “Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up.”, J Alzheimers Dis, vol. 49, no. 3, pp. 607-16, 2016.
H. B. Mehta, Mehta, V., Tsai, C. - L., Chen, H., Aparasu, R. R., and Johnson, M. L., “Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension.”, J Alzheimers Dis, vol. 49, no. 2, pp. 423-32, 2016.
E. Stogmann, Moser, D., Klug, S., Gleiss, A., Auff, E., Dal-Bianco, P., Pusswald, G., and Lehrner, J., “Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1043-50, 2016.
N. Kandiah, Chander, R. Jude, Lin, X., Ng, A., Poh, Y. Yeong, Cheong, C. Yee, Cenina, A. Rae, and Assam, P. Nkouibert, “Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
E. M. Arroyo-Anlló, Bouston, A. Turpin, Fargeau, M. - N., Baz, B. Orgaz, and Gil, R., “Self-Consciousness in Patients with Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1021-9, 2016.
B. K. Lebowitz, Weinstein, C., Beiser, A., Seshadri, S., Wolf, P. A., Auerbach, S., and Au, R., “Lifelong Reading Disorder and Mild Cognitive Impairment: Implications for Diagnosis.”, J Alzheimers Dis, vol. 50, no. 1, pp. 41-5, 2016.
B. K. Lebowitz, Weinstein, C., Beiser, A., Seshadri, S., Wolf, P. A., Auerbach, S., and Au, R., “Lifelong Reading Disorder and Mild Cognitive Impairment: Implications for Diagnosis.”, J Alzheimers Dis, vol. 50, no. 1, pp. 41-5, 2016.
M. Carmona-Iragui, Fernández-Arcos, A., Alcolea, D., Piazza, F., Morenas-Rodriguez, E., Antón-Aguirre, S., Sala, I., Clarimón, J., Dols-Icardo, O., Camacho, V., Sampedro, F., Munuera, J., Nuñez-Marin, F., Lleo, A., Fortea, J., Gómez-Ansón, B., and Blesa, R., “Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
M. Carmona-Iragui, Fernández-Arcos, A., Alcolea, D., Piazza, F., Morenas-Rodriguez, E., Antón-Aguirre, S., Sala, I., Clarimón, J., Dols-Icardo, O., Camacho, V., Sampedro, F., Munuera, J., Nuñez-Marin, F., Lleo, A., Fortea, J., Gómez-Ansón, B., and Blesa, R., “Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., “Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.”, J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., “Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.”, J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., “Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.”, J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
A. Malishkevich, Marshall, G. A., Schultz, A. P., Sperling, R. A., Aharon-Peretz, J., and Gozes, I., “Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.”, J Alzheimers Dis, vol. 50, no. 1, pp. 249-60, 2016.

Pages